menu search

STE / Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Steris: Non-GAAP Valuations Supportive Of Substantial Upside
STERIS has been traded down in recent months with sellers driving price action to the downside since April. Despite this, we believe shares still offer compelling value when examining STE's true corporate value. Read More
Posted: Sep 4 2022, 01:30
Author Name: Seeking Alpha
Views: 111666

STE News  

Steris (STE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

By Zacks Investment Research
November 2, 2023

Steris (STE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Beyond analysts' top -and-bottom-line estimates for Steris (STE), evaluate projections for some of its key metrics to gain a better insight into how t more_horizontal

STERIS' (STE) Improved Volume, New Buyouts Drive Growth

By Zacks Investment Research
October 17, 2023

STERIS' (STE) Improved Volume, New Buyouts Drive Growth

On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments. more_horizontal

Here's Why Investors Should Retain STERIS (STE) Stock for Now

By Zacks Investment Research
September 27, 2023

Here's Why Investors Should Retain STERIS (STE) Stock for Now

STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism. more_horizontal

Here's Why Investors Should Retain STERIS (STE) Stock for Now

By Zacks Investment Research
August 22, 2023

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS' (STE) successful integration of the recently-acquired business and raised guidance. more_horizontal

Steris (STE) Q1 Earnings and Revenues Beat Estimates

By Zacks Investment Research
August 1, 2023

Steris (STE) Q1 Earnings and Revenues Beat Estimates

Steris (STE) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $ more_horizontal

Medical device maker Steris lifts 2024 results view, records quarterly beat

By Reuters
August 1, 2023

Medical device maker Steris lifts 2024 results view, records quarterly beat

Medical equipment provider Steris on Tuesday raised its profit forecast for fiscal 2024 after strength in its core healthcare business boosted first-q more_horizontal

STERIS (STE) Buys Surgical Instrumentation Platform From BDX

By Zacks Investment Research
June 22, 2023

STERIS (STE) Buys Surgical Instrumentation Platform From BDX

STERIS (STE) announces the buyout of surgical instrumentation assets from Becton, Dickinson and Company in a $540 million transaction. more_horizontal

Steris paying $540 mln for BD surgical instrument unit

By Market Watch
June 20, 2023

Steris paying $540 mln for BD surgical instrument unit

Becton, Dickinson and Co. (BD) BDX, +0.96% said Tuesday it agreed to sell its surgical instrumentation platform to Steris for STE, +0.04% for $540 mil more_horizontal


Search within

Pages Search Results: